|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.850 USD | +8.74% |
|
+26.96% | -37.18% |
| 07-07 | RBC Capital Adjusts Verastem Price Target to $14 From $15, Maintains Outperform Rating | MT |
| 06-29 | Verastem, Inc.(NasdaqCM:VSTM) dropped from Russell Small Cap Comp Value Benchmark | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 392M | - | - | - | ||
| 57.73B | |||||
| 54.69B | |||||
| 24.18B | - | ||||
| 23.75B | - | ||||
| 19.82B |
- Stock Market
- Stocks
- VSTM Stock
- Charts Verastem, Inc.
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
